US Business

Aston Martin plans to build and sell 38 of its Valiant coupes–a road-legal, twin-turbo V-12 engine special-edition model.

Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up.

The jet manufacturer has proposed using mostly stock to reacquire the supplier.

Airbus shares in Paris slumped 12% after it lowered its commercial aircraft delivery goal and cut financial targets for the year due to supply-chain hurdles and an impairment related to its space activities.

Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.

With the deal, Brookfield aims to bolster exposure to renewables and battery-storage technology and to accelerate Neoen’s portfolio expansion.

A General Dynamics facility slated to make artillery shells is part of the Pentagon’s $6 billion push to produce more munitions domestically.

The European Union slapped a raft of new sanctions on Russia over its full-scale invasion of Ukraine, targeting the Kremlin’s liquefied natural gas shipments for the first time.

Sonoco Products said it is buying Eviosys from KPS Capital Partners for around $3.9 billion as it seeks to be the leading metal food can and aerosol packaging manufacturer globally.

The opinionated ‘First Take’ co-host has been offered $18 million a year to stay, a sign of his growing importance to the network.